La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Pro Medicus a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Pro Medicus..

Pro Medicus (OTC:PMDIY) Azioni, Catena delle Opzioni

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

PRO MEDICUS LTD U/ADR by Pro Medicus, Ltd.

Pro Medicus Ltd

The estimated impact from the series of changes in U.S. tariff policy at this time is reflected in the above forecasts for operating income, income before income taxes and net income attributable to Sony Group Corporation's stockholders. The estimated impact is calculated based on the assumptions that the reciprocal tariff rates announced on April 2, 2025 will be applied after the end of the temporary suspension announced on April 9, and that other tariffs will remain unchanged from the end of April. The impact of the partial removal and temporary suspension of the additional and reciprocal tariffs on China by the U.S. announced on May 12 is not included in the assumptions used for estimating the relevant impact. The actual impact could vary significantly from this estimation if future tariff policy or other factors are changed.

News

Guidance

Sony Group Corporation American Depositary Shares

SONY

Sony's Forecast Factors In U.S. Tariffs As Of April But Excludes The May 12 China Tariff Changes; The Company Noted The Actual Impact May Vary With Future Policy Shifts

President Donald Trump singled out Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang for praise during a U.S.-Saudi Investment Forum on Tuesday, highlighting the chipmaker&#8217;s planned $500 billion <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">investment in U.S. artificial intelligence infrastructure</a>.
What Happened: &#8220;I see my friend is here, Jensen. [Apple Inc. CEO] Tim Cook isn&#8217;t here, but you are,&#8221; Trump said at the Saudi summit. &#8220;What a job you&#8217;ve done. He&#8217;s got 99% of the chip market. That&#8217;s not easy to beat.&#8221;
Trump&#8217;s comments came as part of a broader announcement of over $1 trillion in investments flowing into the United States. The president specifically acknowledged Huang&#8217;s commitment to building AI infrastructure in America over the next four years.
&#8220;Thank you for the investment. We are proud to have you in our country,&#8221; Trump told Huang, who was present at the forum.
The praise follows Nvidia&#8217;s <a href="https://www.benzinga.com/25/04/44799936/nvidia-to-build-500b-ai-infrastructure-in-us-in-the-next-four-years-details">April announcement of plans to partner with manufacturers</a> including Foxconn, Wistron, TSMC, Amkor, and SPIL to establish production centers in Arizona and Texas. Production of Nvidia&#8217;s Blackwell chips is already underway at TSMC&#8217;s Phoenix facility.
See Also: <a href="https://www.benzinga.com/markets/bonds/25/05/45396490/peter-schiff-says-trade-truce-aside-the-world-is-losing-confidence-in-dollar-and-in-us-ability-to-put-fiscal-house-in-order">Peter Schiff Says Trade Truce Aside, The World Is &#8216;Losing Confidence&#8217; In Dollar And In US Ability To Put &#8216;Fiscal House In Order&#8217;</a>
Why It Matters: The comments coincide with Nvidia&#8217;s stock rally, which has driven the company <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">back into the $3 trillion market cap club</a>. Shares surged following Monday&#8217;s de-escalation in U.S.-China trade tensions and Tuesday&#8217;s announcement of a deal to supply 18,000 GB300 Blackwell chips to Saudi-based AI startup Humain.
Huang, whose <a href="https://www.benzinga.com/markets/25/05/45397196/jensen-huangs-wealth-surges-37-since-liberation-day-lows-as-nvidia-re-enters-3-trillion-market-cap-club-on-saudi-chip-pact">net worth stood at approximately $114 billion on Tuesday</a>, has seen his fortune increase 37% since early April lows following the &#8220;Liberation Day&#8221; tariffs announcement.
The Nvidia investment was mentioned alongside other major U.S. commitments, including Apple Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) $500 billion investment and Taiwan Semiconductor Manufacturing Company&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) $200 billion investment.
Photo Courtesy: jamesonwu1972 on Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45396297/cathie-wood-dumps-palantir-as-stock-touches-peak-prices-bails-on-soaring-flying-taxi-maker-archer-aviation">Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

AAPL

NVDA

Trump Praises Nvidia CEO Jensen Huang At Saudi Summit: 'Tim Cook Isn't Here, But You Are' Controlling 99% Of The Chip Market: 'That's Not Easy To Beat'

Earnings

Sony's Forecast For Fiscal Year Ending March 31, 2026: Expects Sales From Continuing Operations Of ¥11.7T (-2.9% YoY), Operating Income Of ¥1.28T (+0.3% YoY), And Net Income Of ¥930B (-12.9% YoY)

Sony Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.12 by 78.33 percent. This is a 1.9 percent increase over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $17.25 billion which missed the analyst consensus estimate of $20.40 billion by 15.46 percent. This is a 26.48 percent decrease over sales of $23.46 billion the same period last year.

Earnings Beats

Earnings Misses

Sony Group Q4 EPS $0.21 Beats $0.12 Estimate, Sales $17.25B Miss $20.40B Estimate

Macro Economic Events

Econ #s

Economics

Germany Consumer Price Index (MoM) For April 0.4% Vs. 0.4% Est.; 0.3% Prior

Germany Consumer Price Index (YoY) For April 2.1% Vs. 2.1% Est.; 2.2% Prior

Sony Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) reported quarterly earnings of ¥187.92 per share which beat the analyst consensus estimate of ¥180.09 by 4.35 percent. This is a 19.59 percent increase over earnings of ¥157.14 per share from the same period last year. The company reported quarterly sales of ¥12.957 trillion which missed the analyst consensus estimate of ¥13.336 trillion by 2.84 percent. This is a 0.48 percent decrease over sales of ¥13.020 trillion the same period last year.

Sony Group FY 2024 GAAP EPS ¥187.92 Beats ¥180.09 Estimate, Sales ¥12.957T Miss ¥13.336T Estimate

Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) will release its third-quarter financial results after the closing <a href="https://www.benzinga.com/quote/CSCO/earnings">bell on Wednesday, May 14.</a>
Analysts expect the San Jose, California-based company to report quarterly earnings at 92 cents per share, up from 88 cents per share in the year-ago period. Cisco projects quarterly revenue of $14.06 billion, compared to $12.7 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 28, Evercore ISI Group analyst Amit Daryanani maintained Cisco with an Outperform rating and lowered the price target from $75 to $67.
The recent buzz around Cisco may have investors eyeing potential gains from the company's dividends. Currently, Cisco offers an annual dividend yield of 2.66%. That&#8217;s a quarterly dividend of 41 cents per share ($1.64 a year).
To figure out how to earn $500 monthly from Cisco, we start with the yearly target of $6,000 ($500 x 12 months).
Next, we take this amount and divide it by Cisco's $1.64 dividend: $6,000 / $1.64 = 3,659 shares.
So, an investor would need to own approximately $225,651 worth of Cisco, or 3,659 shares to generate a monthly dividend income of $500.
Assuming a more conservative goal of $100 monthly ($1,200 annually), we do the same calculation: $1,200 / $1.64 = 732 shares, or $45,142 to generate a monthly dividend income of $100.
Investors should note that dividend yields can change on a rolling basis. The dividend payment and the stock price both fluctuate over time.
The dividend yield is calculated by dividing the annual dividend payment by the current stock price. As the stock price changes, the dividend yield will also change.
For example, if a stock pays an annual dividend of $2 and its current price is $50, its dividend yield would be 4%. However, if the stock price increases to $60, the dividend yield would decrease to 3.33% ($2/$60).
Conversely, if the stock price decreases to $40, the dividend yield would increase to 5% ($2/$40).
Further, the dividend payment itself can also change over time, which can also impact the dividend yield. If a company increases its dividend payment, the dividend yield will increase even if the stock price remains the same. Similarly, if a company decreases its dividend payment, the dividend yield will decrease.
CSCO Price Action: Shares of Cisco gained by 3.2% to close at $61.67 on Monday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/05/45347009/top-2-tech-stocks-that-may-crash-in-q2">Top 2 Tech Stocks That May Crash In Q2</a></li>
</ul>
Image: Shutterstock

Long Ideas

Trading Ideas

CSCO

How To Earn $500 A Month From Cisco Stock Ahead Of Q3 Earnings

Bluejay Diagnostics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BJDX#NASDAQ">BJDX</a>) reported quarterly losses of $(3.37) per share. This is a 99.15 percent increase over losses of $(394.76) per share from the same period last year.

BJDX

Bluejay Diagnostics Q1 EPS $(3.37) Up From $(394.76) YoY

Investcorp Credit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICMB#NASDAQ">ICMB</a>) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.11 by 54.55 percent. This is a 64.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $4.37 million which missed the analyst consensus estimate of $5.27 million by 17.13 percent. This is a 34.00 percent decrease over sales of $6.62 million the same period last year.

ICMB

Investcorp Credit Q3 EPS $0.05 Misses $0.11 Estimate, Sales $4.37M Miss $5.27M Estimate

Belite Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLTE#NASDAQ">BLTE</a>) reported quarterly losses of $(0.45) per share which missed the analyst consensus estimate of $(0.35) by 28.57 percent. This is a 36.36 percent decrease over losses of $(0.33) per share from the same period last year.

BLTE

Belite Bio Q1 EPS $(0.45) Misses $(0.35) Estimate

Tvardi Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVRD#NASDAQ">TVRD</a>) reported quarterly losses of $(3.22) per share which missed the analyst consensus estimate of $(0.31) by 938.71 percent. This is a 84.09 percent increase over losses of $(20.24) per share from the same period last year. The company reported $2.57 million in sales this quarter. This is a 20.33 percent increase over sales of $2.13 million the same period last year.

TVRD

Tvardi Therapeutics Q1 EPS $(3.22) Misses $(0.31) Estimate, Sales $2.57M Up From $2.13M YoY

Reported Earlier, GreenPower Motor Announces $2M Term Loan Offering To Support Production And Working Capital

Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) reported quarterly losses of $(2.75) per share. This is a 49.45 percent increase over losses of $(5.44) per share from the same period last year.

PTIX

Protagenic Therapeutics Q1 EPS $(2.75) Up From $(5.44) YoY

Hall Of Fame Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFV#NASDAQ">HOFV</a>) reported quarterly losses of $(2.30) per share which missed the analyst consensus estimate of $(2.23) by 3.14 percent. This is unchanged from the same period last year. The company reported quarterly sales of $2.94 million which missed the analyst consensus estimate of $3.75 million by 21.47 percent. This is a 29.73 percent decrease over sales of $4.19 million the same period last year.

HOFV

Hall Of Fame Resort Q1 EPS $(2.30) Misses $(2.23) Estimate, Sales $2.94M Miss $3.75M Estimate

Korea's sixth-generation supercomputer, KISTI-6, will be 100% direct liquid-cooled to enable AI and HPC simulation for researchers across academia and industry

Reported Earlier, Hewlett Packard Enterprise Selected By KISTI To Deliver South Korea's Sixth-Generation, AI-Powered Supercomputer

Uber estimates that the net proceeds from the offering will be approximately $978.9 million (or $1,125.9 million if the initial purchaser exercises its option to purchase additional notes in full), after deducting the initial purchaser's discount and estimated offering expenses payable by Uber. Uber intends to use the net proceeds from the offering for general corporate purposes, which may include strategic investments, although Uber has not designated any specific uses at this time.

UBER

Reported Earlier, Uber Prices $1B In 0.0% Exchangeable Senior Notes Due 2028, Exchangeable Into Aurora Innovation Stock

Kezar Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZR#NASDAQ">KZR</a>) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(2.61) by 13.03 percent. This is a 24.33 percent increase over losses of $(3.00) per share from the same period last year.

Kezar Life Sciences Q1 EPS $(2.27) Beats $(2.61) Estimate

Avalon Globocare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALBT#NASDAQ">ALBT</a>) reported quarterly losses of $(1.43) per share. This is a 20.56 percent increase over losses of $(1.80) per share from the same period last year. The company reported $349.80 thousand in sales this quarter. This is a 11.19 percent increase over sales of $314.59 thousand the same period last year.

ALBT

Avalon Globocare Q1 EPS $(1.43) Up From $(1.80) YoY, Sales $349.80K Up From $314.59K YoY

Pluri (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUR#NASDAQ">PLUR</a>) reported quarterly losses of $(0.94) per share. This is a 6.93 percent increase over losses of $(1.01) per share from the same period last year. The company reported $427.00 thousand in sales this quarter. This is a 501.41 percent increase over sales of $71.00 thousand the same period last year.

Comments

Pro Medicus

Pro Medicus (PMDIY) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO